Navigation Links
Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight

Scientists have developed a new class of drugs called antisense drugs, which can block the genes associated with production of harmful proteins//. Until now, it has been difficult for scientists to find a way by which special cancer drugs can be prevented from breaking down before they reach the target genes.

But now, this problem can be overcome by combining the drugs with small gold particles. This novel finding has been the result of the sustained efforts of researchers at the Northwestern University.

Cancer and a spectrum of other disorders arise as a result of a subtle alteration in the genetic material (mutation). Mutation in a gene results in excessive production of copies of certain proteins that can pave way for cancer and other disorders.

The conventional drugs target these excess or harmful proteins while the new generation drugs (antisense drugs) target the genetic material itself, inhibiting production of the harmful protein. Although this new form of therapy is in a preliminary stage, it promises to be more effective than all forms of existing drug treatment.

When extremely small gold particles (a fraction of the width of the human hair) are attached to multiple strands of antisense DNA, it resulted in a stable delivery of these drugs to the required site of action. Less toxicity and ready absorption of these drugs into cells offer a unique advantage of this particular form of therapy.

‘In the future, this exciting new class of antisense material could be used for the treatment of cancer and other diseases that have a genetic basis. Once inside cells, the DNA modified nanoparticles act as sponges that bind to their targets and prevent them from being converted to proteins,’ said Chad Mirkin, lead author of the study.

‘Powerful new cancer drugs will only live up to their potential if they can be efficiently delivered to cancer cells. This study accomplishes this by combining two exciting and relatively new technologies - antisense drugs and nanotechnology. In upcoming years, we are likely to see nanotechnology play a greater role in detecting and treating cancers,’ said Ed Yong of the Cancer Research, UK.

Source: Eurekaler
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... Eau Claire, WI (PRWEB) , ... March 27, ... ... currently accepting new patients for custom smile makeovers without requiring a ... needs including orthodontics, gum disease treatment, cosmetic dentistry and dental implants. Whether patients ...
(Date:3/27/2017)... and London UK (PRWEB) , ... March 27, ... ... speed, agility and ability to gain site attention and engagement over the household ... educational webinar will discuss how partnering with the right outsourcing ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... it will co-exhibit with technology partners LG Business Solutions at ATARC Federal ... Center in Washington D.C., will provide education and examination into the mobility tools ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first ... for the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to ... such as ANSI, ISO and proven test methods used in the field of ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be commonplace ... injury, it occurs when the muscles around the pelvis become inflamed. Over time, ... lower torso, as well as accompanying tenderness and weakness. Without proper intervention, it ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 Elysium Health joins ... Cambridge academic scientists ... The Milner Therapeutics Institute today announces Elysium Health as ... committed significant investment for collaborative projects with academic researchers in ... This is the first major research investment outside the U.S. ...
(Date:3/27/2017)... Summary This report provides all the ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
(Date:3/27/2017)... 27, 2017 Therapix Biosciences ... company specializing in the development of cannabinoid-based drugs, today ... the United States of ... 40 ordinary shares of the Company, at a ... has granted the underwriters a 45-day over-allotment option ...
Breaking Medicine Technology: